PMID- 30371602 OWN - NLM STAT- MEDLINE DCOM- 20191112 LR - 20191112 IS - 2380-0194 (Electronic) IS - 2380-0186 (Linking) VI - 31 IP - 10 DP - 2018 Dec TI - Treatment of Cervical Myelopathy: Long-term Outcomes of Arthroplasty for Myelopathy Versus Radiculopathy, And Arthroplasty Versus Arthrodesis for Myelopathy. PG - 420-427 LID - 10.1097/BSD.0000000000000744 [doi] AB - STUDY DESIGN: Analysis of 2- and 7-year outcomes from a clinical trial comparing 2-level cervical disk arthroplasty (CDA) to anterior cervical discectomy and fusion (ACDF) in 287 patients with radiculopathy alone, and 110 patients with myelopathy alone or myelopathy with radiculopathy. OBJECTIVE: To compare the long-term safety and effectiveness of CDA for myelopathy versus radiculopathy. SUMMARY OF BACKGROUND DATA: CDA for myelopathy is safe and effective in short term. MATERIALS AND METHODS: We analyzed Neck Disability Index (NDI), neck/arm pain, SF-36, neurological status, adverse events (AEs), and secondary surgeries at index and adjacent levels. RESULTS: All groups improved significantly for NDI, neck/arm pain, and physical component summary (PCS) scores from preoperative to postoperative. CDA Myelopathy versus CDA Radiculopathy: 2- and 7-year improvements were not significantly different. The 7-year score improvements for CDA Myelopathy and CDA Radiculopathy were: NDI (37.8 vs. 35.8, P=0.352), neck pain (12.0 vs. 12.1, P=0.477), arm pain (11.6 vs. 9.6, P=0.480), and PCS (14.1 vs. 13.7, P=0.863). The 2 groups had similar proportions of patients who maintained or improved their neurological status (87.2% vs. 93.5%, P=0.218), similar rates of serious AEs (54.5% vs. 57.5%, P=0.291) and similar rates of secondary surgeries at index (3.7% vs. 4.4%, P=0.839) and adjacent levels (3.7% vs. 7.6%, P=0.367). CDA Myelopathy versus ACDF myelopathy: 2 and 7-year improvements were not significantly different. The 7-year CDA and ACDF score improvements were: NDI (37.8 vs. 31.1, P=0.147), neck pain (12.0 vs. 10.4, P=0.337), arm pain (11.6 vs. 11.4, P=0.791), and PCS (14.1 vs. 11.2, P=0.363). The 2 groups had statistically similar proportions who maintained or improved their neurological status (87.2% vs. 96.2%, P=0.409), statistically similar overall rates of secondary surgeries at the index levels (3.7% vs. 9.4%, P=0.374), and statistically similar rates of secondary surgeries at adjacent levels (3.7% vs. 15.4%, P=0.088). CDA group demonstrated lower rates of serious AEs than ACDF (54.5% vs. 65.9%, P=0.019). CONCLUSIONS: CDA for myelopathy is a safe and effective long-term treatment. FAU - Gornet, Matthew F AU - Gornet MF AD - The Orthopedic Center of St. Louis, St Louis, MO. FAU - McConnell, Jeffrey R AU - McConnell JR AD - OAA Orthopaedic Specialists, Allentown, PA. FAU - Riew, K Daniel AU - Riew KD AD - Department of Orthopaedic Surgery, Columbia University Medical Center, New York, NY. FAU - Lanman, Todd H AU - Lanman TH AD - California Spine Group, Century City Hospital, Los Angeles, CA. FAU - Burkus, J Kenneth AU - Burkus JK AD - Wilderness Spine Services, Columbus, GA. FAU - Hodges, Scott D AU - Hodges SD AD - Center for Sports Medicine and Orthopedics, Chattanooga, TN. FAU - Dryer, Randall F AU - Dryer RF AD - Central Texas Spine Institute, Austin, TX. FAU - Copay, Anne G AU - Copay AG AD - SPIRITT Research, St. Louis, MO. FAU - Schranck, Francine W AU - Schranck FW AD - SPIRITT Research, St. Louis, MO. LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Clin Spine Surg JT - Clinical spine surgery JID - 101675083 SB - IM MH - Arthroplasty MH - *Cervical Vertebrae MH - Female MH - Humans MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Radiculopathy MH - Spinal Cord Diseases/*surgery MH - Spinal Fusion MH - Treatment Outcome EDAT- 2018/10/30 06:00 MHDA- 2019/11/13 06:00 CRDT- 2018/10/30 06:00 PHST- 2018/10/30 06:00 [pubmed] PHST- 2019/11/13 06:00 [medline] PHST- 2018/10/30 06:00 [entrez] AID - 10.1097/BSD.0000000000000744 [doi] PST - ppublish SO - Clin Spine Surg. 2018 Dec;31(10):420-427. doi: 10.1097/BSD.0000000000000744.